SLXN Silexion Therapeutics Corp.
Fundamentals / CIK 0002022416 / USDSilexion Therapeutics Corp. reported $6.83M in total assets and a net loss of $13.23M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SLXN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$13.52M Operating profit
-
Net Income FY 2025-$13.23M GAAP bottom line
-
Diluted EPS FY 2025-$71.54 Split-adjusted
-
Free Cash Flow FY 2025-$11.74M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$4.76M Total debt: $374K
Annual revenue and net income
3 fiscal years (2023 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Research & Development | $7.14M | $5.82M | $3.71M |
| Total Operating Expenses | $11.63M | $12.57M | $4.68M |
| Operating Income | -$11.63M | -$12.57M | -$4.68M |
| EBITDA | -$11.62M | -$12.55M | -$4.64M |
| Interest Income | $155K | $28K | $153K |
| Income Before Tax | -$11.91M | -$16.51M | -$5.08M |
| Income Tax Expense | $3.0K | $10K | $32K |
| Net Income | -$11.91M | -$16.52M | -$5.11M |
| Basic EPS | $21,333.33 | $940,333.33 | $7,187,382,187.38 |
| Diluted EPS | $21,333.33 | $940,333.33 | $7,187,382,187.38 |
| Basic Shares Outstanding | 558 | 17 | 0 |
| Diluted Shares Outstanding | 558 | 17 | 0 |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $1.29M | $2.21M | $1.37M | $3.38M | $2.16M | $1.02M | $590K | $871K |
| Total Operating Expenses | $2.68M | $3.68M | $2.75M | $4.41M | $3.29M | $2.28M | $1.65M | $1.90M |
| Operating Income | -$2.68M | -$3.68M | -$2.75M | -$4.41M | -$3.29M | -$2.28M | -$1.65M | -$1.90M |
| EBITDA | -$2.68M | -$3.68M | -$2.75M | -$4.40M | -$3.29M | -$2.28M | -$1.65M | -$1.91M |
| Interest Income | $18K | $14K | $32K | $69K | $39K | $44K | $2.0K | $3.0K |
| Income Before Tax | -$2.53M | -$3.55M | -$2.73M | -$4.41M | -$3.26M | -$2.50M | -$1.74M | -$1.75M |
| Income Tax Expense | -- | -- | -- | -- | $0 | $3.0K | -- | $1.0K |
| Net Income | -$2.53M | -$3.55M | -$2.73M | -$4.41M | -$3.26M | -$2.50M | -$1.74M | -$1.75M |
| Basic EPS | $13.70 | $1,230.95 | $2,023.81 | -- | $691.14 | $10,283.33 | $9,142.86 | -- |
| Diluted EPS | $13.70 | $1,230.95 | $2,023.81 | -- | $691.14 | $10,283.33 | $9,142.86 | -- |
| Basic Shares Outstanding | 184.9K | 2.9K | 1.4K | -- | 4.7K | 243 | 190 | -- |
| Diluted Shares Outstanding | 184.9K | 2.9K | 1.4K | -- | 4.7K | 243 | 190 | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Cash & Cash Equivalents | $5.99M | $1.19M | $4.59M |
| Cash & Short-Term Investments | $5.99M | $1.19M | $4.59M |
| Other Current Assets | $49K | $62K | $24K |
| Total Current Assets | $6.64M | $2.25M | $4.98M |
| Property, Plant & Equipment, Net | $25K | $30K | $49K |
| Total Non-Current Assets | $578K | $613K | $277K |
| Total Assets | $7.21M | $2.86M | $5.26M |
| Accounts Payable | $787K | $929K | $319K |
| Other Current Liabilities | -- | $0 | $200K |
| Total Current Liabilities | $2.76M | $3.52M | $2.20M |
| Total Non-Current Liabilities | $1.85M | $3.33M | $59K |
| Total Liabilities | $4.61M | $6.85M | $2.25M |
| Total Debt (incl. Leases) | $468K | $526K | $171K |
| Common Stock | $42K | $2.0K | $1.0K |
| Retained Earnings | -$55.17M | -$43.25M | -$26.81M |
| Total Stockholders' Equity | $2.60M | -$3.99M | -$15.48M |
| Total Equity | $2.60M | -$3.99M | $3.00M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $4.76M | $2.23M | $2.41M | $5.99M | $9.24M | $3.47M | $6.15M | $1.19M |
| Cash & Short-Term Investments | $4.76M | $2.23M | $2.41M | $5.99M | $9.24M | $3.47M | $6.15M | $1.19M |
| Other Current Assets | $102K | $111K | $96K | $49K | $47K | $63K | $58K | $62K |
| Total Current Assets | $6.11M | $3.74M | $4.07M | $6.64M | $11.05M | $5.24M | $7.72M | $2.25M |
| Property, Plant & Equipment, Net | $21K | $20K | $23K | $25K | $26K | $30K | $32K | $30K |
| Total Non-Current Assets | $716K | $505K | $537K | $578K | $559K | $560K | $586K | $613K |
| Total Assets | $6.83M | $4.25M | $4.60M | $7.21M | $11.61M | $5.80M | $8.31M | $2.86M |
| Accounts Payable | $1.24M | $1.18M | $912K | $787K | $946K | $692K | $722K | $929K |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $0 |
| Total Current Liabilities | $3.68M | $3.98M | $4.06M | $2.76M | $2.79M | $2.15M | $2.40M | $3.52M |
| Total Non-Current Liabilities | $178K | $226K | $251K | $1.85M | $1.85M | $3.53M | $3.33M | $3.33M |
| Total Liabilities | $3.86M | $4.20M | $4.31M | $4.61M | $4.64M | $5.68M | $5.72M | $6.85M |
| Total Debt (incl. Leases) | $374K | $425K | $436K | $468K | $485K | $508K | $489K | $526K |
| Common Stock | $1.95M | $160K | $46K | $42K | $42K | $8.0K | $8.0K | $2.0K |
| Retained Earnings | -$63.98M | -$61.45M | -$57.90M | -$55.17M | -$50.75M | -$47.49M | -$44.99M | -$43.25M |
| Total Stockholders' Equity | $2.97M | $44K | $291K | $2.60M | $6.98M | $120K | $2.59M | -$3.99M |
| Total Equity | $2.97M | $44K | $291K | $2.60M | $6.98M | $120K | $2.59M | -$3.99M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Net Income | -$11.91M | -$16.52M | -$5.11M |
| Depreciation & Amortization | $14K | $25K | $45K |
| Stock-Based Compensation | $134K | $5.86M | $130K |
| Change in Payables | -$142K | $610K | $79K |
| Operating Cash Flow | -$10.82M | -$8.40M | -$4.53M |
| Capital Expenditure | -$9.0K | -$22K | -$12K |
| Free Cash Flow | -$10.83M | -$8.42M | -$4.54M |
| Investing Cash Flow | -$14K | -$22K | $573K |
| Financing Cash Flow | $15.64M | $5.10M | $522K |
| Net Change in Cash | $4.81M | -$3.31M | -$3.43M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$2.53M | -$3.55M | -$2.73M | -$4.41M | -$3.26M | -$2.50M | -$1.74M | -$1.75M |
| Depreciation & Amortization | $2.0K | $3.0K | $2.0K | $3.0K | $4.0K | $3.0K | $4.0K | -$12K |
| Stock-Based Compensation | $16K | $197K | $345K | $38K | $38K | $37K | $21K | $0 |
| Change in Payables | $64K | $268K | $125K | -$159K | $254K | -$30K | -$207K | $131K |
| Operating Cash Flow | -$2.11M | -$2.92M | -$3.65M | -$3.02M | -$2.84M | -$2.51M | -$2.45M | -$2.93M |
| Capital Expenditure | -$42K | $0 | $0 | -$2.0K | $0 | -$1.0K | -$6.0K | $0 |
| Free Cash Flow | -$2.15M | -$2.92M | -$3.65M | -$3.02M | -$2.84M | -$2.51M | -$2.46M | -$2.93M |
| Investing Cash Flow | -$42K | -$1.0K | $0 | -$7.0K | $0 | -$1.0K | -$6.0K | $0 |
| Common Stock Issued | $1.90M | $1.99M | $83K | -- | $0 | $0 | $0 | -- |
| Financing Cash Flow | $4.70M | $2.74M | $83K | -$221K | $8.62M | -$195K | $7.43M | -- |
| Net Change in Cash | $2.55M | -$186K | -$3.56M | -$3.24M | $5.78M | -$2.70M | $4.97M | -$742K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Return on Equity (ROE) | -457.6% | -- | -- |
| Return on Assets (ROA) | -165.1% | -577.0% | -97.2% |
| Current Ratio | 2.41x | 0.64x | 2.27x |
| Quick Ratio | 2.17x | 0.34x | 2.09x |
| Debt to Equity | 0.18x | -- | -- |
| EPS Growth (YoY) | -97.7% | -100.0% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -445.7% | -31722.7% | -4436.4% | -457.6% | -132.5% | -14870.8% | -650.9% | -- |
| Return on Assets (ROA) | -193.8% | -328.7% | -280.5% | -165.1% | -79.6% | -307.8% | -202.6% | -577.0% |
| Current Ratio | 1.66x | 0.94x | 1.00x | 2.41x | 3.97x | 2.44x | 3.22x | 0.64x |
| Quick Ratio | 1.29x | 0.56x | 0.59x | 2.17x | 3.32x | 1.61x | 2.57x | 0.34x |
| Debt to Equity | 0.13x | 9.66x | 1.50x | 0.18x | 0.07x | 4.23x | 0.19x | -- |
| EPS Growth (YoY) | -98.0% | -88.0% | -77.9% | -- | -100.0% | -100.0% | -100.0% | -- |